Cefprozil — Compare Prices at US & Canada Pharmacies

• Healthcare providers can prescribe multiple antibiotic options to replace amoxicillin, depending on factors like the specific bacteria causing infection, a patient's medical background, and potential adverse effects.
• Augmentin, cephalexin, cefdinir, azithromycin (Zithromax), and doxycycline rank among the most frequently prescribed alternatives.
• Distinguishing between bacterial and viral infections is essential, since antibiotics are ineffective against viruses.

Doctors frequently prescribe amoxicillin to combat various bacterial infections—ranging from skin conditions and middle ear infections to sinusitis, pharyngitis, urinary tract infections, pneumonia, and bronchitis. However, this antibiotic may not be suitable for every patient. Reasons a doctor might choose a different medication include antibiotic resistance, penicillin hypersensitivity, the specific type of infection, or potential drug interactions. Fortunately, physicians have access to numerous antibiotics from different drug classes capable of treating the same bacterial infections that amoxicillin addresses.

Amoxicillin is classified as a penicillin-type antibiotic. If amoxicillin becomes unavailable, other penicillin-class drugs may be considered, including penicillin itself. However, bacterial resistance to beta-lactams—the active component that destroys bacteria—can reduce penicillin effectiveness. When resistance occurs, doctors often prescribe amoxicillin combined with clavulanate, a compound that blocks the bacterial defense mechanism responsible for resisting beta-lactam antibiotics.

Due to penicillin allergies, many patients cannot tolerate penicillin-type drugs. For those with mild allergic reactions (such as rash-only responses), cephalosporin antibiotics represent a viable alternative; these medications are identifiable by names beginning with "ceph-" or "cef-."

Beyond cephalosporins, macrolide antibiotics (identifiable by the "-mycin" suffix), tetracycline agents (identifiable by the "-cycline" suffix), and sulfonamide drugs (starting with "sulfa-") provide additional substitution options. Fluoroquinolone antibiotics ending in "-oxacin," such as levofloxacin, also serve as possible alternatives.

Here are some of the most common substitutes for amoxicillin used across different patient populations and infection types.

Augmentin (amoxicillin-clavulanate) merges amoxicillin with clavulanate, a beta-lactamase inhibitor that overcomes bacterial resistance in penicillin-susceptible microorganisms. Clinicians typically select it as the initial therapy when drug-resistant bacteria are suspected—particularly for ear infections, sinusitis, and respiratory tract infections. Patients with documented penicillin allergy should not receive this combination.

Cephalexin belongs to the first-generation cephalosporin class and works well for individuals with mild penicillin sensitivity—those who experienced only minor rashes from prior amoxicillin exposure. Healthcare providers frequently prescribe it for strep throat and skin infections like cellulitis in other patient populations.

Third-generation cephalosporins like cefdinir provide expanded bacterial coverage and can treat acute middle ear infections and pneumonia when amoxicillin fails. These agents also address urinary tract infections—conditions for which amoxicillin is rarely first-line. Once-daily dosing represents a practical advantage. However, because these potent agents also eliminate beneficial intestinal bacteria, physicians typically recommend them only when less aggressive alternatives prove insufficient.

Azithromycin (Zithromax) has been widely used for strep throat and respiratory tract infections in penicillin-allergic patients. Its once-daily dosing schedule and five-day treatment duration have made it a popular choice. Recently, however, increasing macrolide resistance has reduced its appeal, and it is no longer recommended as first-line therapy for acute bacterial sinusitis or acute otitis media in most patients.

Sinusitis, pneumonia, and Lyme disease respond to doxycycline, a tetracycline antibiotic, making it a practical option in many situations where amoxicillin is unsuitable or ineffective. Tetracyclines do carry notable drawbacks: gastrointestinal upset and photosensitivity occur frequently, and prolonged use in young children raises concerns about tooth discoloration.

Nonprescription topical antibiotics are designed primarily for wound and burn care to prevent surface bacterial contamination. They are not effective against many common or serious skin infections, including badly infected wounds, acne, rosacea, cellulitis, and related conditions. These products must never be swallowed or placed inside the ear, mouth, nose, or rectum to treat systemic or localized internal bacterial infections.

Multiple natural foods and plant compounds possess antibacterial properties. Research has documented antimicrobial compounds in garlic (sulfur-based molecules), honey (hydrogen peroxide), oregano, clove (eugenol), and ginger, with the latter showing potential to inhibit microbial activity. When used appropriately, these substances are safe dietary additions that may support prevention of minor bacterial infections. They lack evidence as effective replacements for FDA-approved antibiotics in treating clinically significant bacterial infections.

Finding an appropriate amoxicillin substitute is often straightforward, whether the reason involves allergy, reduced efficacy, intolerable side effects, or cost concerns. The selection process requires careful analysis of the causative bacteria and the appropriate antibiotic strength. Your healthcare team will examine all current medications—prescription, over-the-counter, and dietary supplements—to identify potential interactions and confirm the absence of allergy concerns. After this review, you will begin treatment with an alternative antibiotic suited to your condition.

Amoxicillin and other antibiotics have no effect on viruses, which present far greater treatment challenges than bacteria. Correct diagnosis from a healthcare provider is the crucial first step. Following diagnosis, a doctor may recommend an antiviral medication, though many viral infections lack approved antiviral therapies. Some viral illnesses resolve spontaneously within days without intervention. Others—including influenza and COVID-19—respond to antiviral treatment, but these medications are typically reserved for patients at elevated risk of severe outcomes or complications.

Sources:

• dailymed.nlm.nih.gov
• www.sciencedirect.com
• www.frontiersin.org
• www.dovepress.com
• www.mdpi.com

• The FDA has designated multiple amoxicillin formulations as currently in shortage, with 23 products listed on its drug shortages page as of late October.
• Oral powder suspension—commonly prescribed to children—represents the majority of affected products, driven by a surge in respiratory infections as children return to school.
• Several alternative antibiotics are available for common bacterial infections that amoxicillin typically treats, including cephalosporins, sulfamethoxazole-trimethoprim, and nitrofurantoin.
• The FDA has not announced a definitive end date for the shortage, though some manufacturers project limited supplies returning by late 2022 or early 2023.

As cold and flu season arrives and more people spend time indoors, a significant shortage of a widely used antibiotic has emerged. The FDA has placed oral powder for suspension amoxicillin on its "currently in shortage" list. As of late October, the agency identified 23 amoxicillin products experiencing supply constraints due to surging demand.

The American Society of Health-Systems Pharmacists (ASHP) has also documented which amoxicillin formulations are affected, cataloging shortages across oral powder for suspension, tablets, chewable tablets, and capsules.

Amoxicillin belongs to the penicillin class of antibiotics. You may recognize it under brand names such as Amoxil or Trimox. When combined with clavulanic acid—a compound that inhibits bacterial resistance—it becomes Augmentin.

Physicians frequently prescribe amoxicillin for bacterial ear infections, respiratory tract infections, and conditions like strep throat. Like all antibiotics, amoxicillin has no effect on viral illnesses including the common cold, flu, RSV, or COVID-19, though it may treat secondary bacterial infections that occasionally develop following viral illness.

Amoxicillin ranks among America's most frequently prescribed antibiotics. The shortage has been amplified by a spike in respiratory infections coinciding with children returning to school and daycare, facilitating rapid disease transmission.

The scarcity primarily affects oral suspension powder—the formulation mixed with water at the pharmacy to create a liquid medication commonly dispensed to young children. This constraint has created challenges for pediatricians and other clinicians who routinely rely on this particular form, forcing many to identify alternative medications for their young patients.

The shortage spans oral amoxicillin products from multiple pharmaceutical manufacturers. Sandoz formulations appear on the FDA's availability list with limited stock for some products and unavailability for others.

Hikma Pharmaceuticals has four products designated as available for current customers. Aurobindo and Teva Pharmaceuticals each have four formulations listed as "on allocation," a term the ASHP defines as products distributed under constraints that restrict supply of scarce materials until shortages resolve—measures that may include capping order quantities or prioritizing availability for patients with life-threatening conditions.

"No, not necessarily," says Laura K. Grubb, MD, MPH, board-certified pediatrician. "Most common infections in young children are viral and do not require antibiotics. The most uses for amoxicillin in young children are ear infections and urinary tract infections and there are sufficient other suitable, effective antibiotics."

The timing of the shortage—coinciding with cold and flu season—understandably raises parental concerns, particularly given recent disruptions to other essential medications and supplies. Yet for most conditions treated with amoxicillin, alternatives exist. If a child can swallow tablets, the pill form may be obtainable. When a pharmacy runs out of stock, the pharmacist can reach out to the prescribing provider to arrange a substitute medication.

"Alternative antibiotic choices depend on the infection. For ear infections, health care providers can consider common cephalosporins such as cephalexin, cefuroxime, cefixime, and cefdinir," explains Dr. Grubb. "For urinary tract infections, health care providers can prescribe a cephalosporin, sulfamethoxazole and trimethoprim (Bactrim), or nitrofurantoin. For pneumonia, a cephalosporin is a good choice. For upper respiratory infections, the culprit is viral, so antibiotics are not indicated."

Providers may select from several substitutes, including cefdinir (Omnicef), cefprozil, cephalexin (Keflex), cefuroxime, sulfamethoxazole-trimethoprim (Bactrim), and amoxicillin-clavulanate (Augmentin).

A precise end date remains uncertain. The FDA has not issued a projected timeline for resolution.

Some unavailable products listed on the FDA's shortages page include expected availability windows. Certain Sandoz products, for instance, are projected to have limited supplies available before year-end 2022, while others are not expected to return until the first quarter of 2023. The ASHP notes that Rising Pharmaceuticals maintains supplies of several amoxicillin capsules and tablets. Because conditions fluctuate rapidly, consulting your healthcare provider or pharmacy for current information is essential before taking action.

Cefprozil is a generic prescription antibiotic belonging to the cephalosporin class of medications. It works by disrupting the bacterial cell wall formation process—similar to how penicillin-based antibiotics function. Once the cell wall is compromised and can no longer remain intact, bacteria cannot maintain cellular structure and ultimately die. Cefprozil treats a variety of bacterial infections, including those affecting the sinuses, throat, tonsils, larynx, skin (including staph and strep infections), middle ear, as well as pneumonia and bronchitis. The medication is available in tablet and oral suspension formulations. Dosage and quantity depend on the specific infection type and severity. Cefprozil is ineffective against viral infections and should only be used when a bacterial infection is confirmed.

Many people tolerate cefprozil well with no side effects, though some experience mild to moderate adverse reactions. Common side effects include diarrhea, nausea, abdominal discomfort, headache, dizziness, an unpleasant aftertaste, and muscle stiffness. In some patients, cefprozil may trigger mood or mental changes such as restlessness and hyperactivity. Allergic reactions to cefprozil can occur and typically present as hives, rashes, dizziness, or breathing difficulty. Anaphylactic shock—a severe and potentially life-threatening allergic response marked by a sudden drop in blood pressure—is a rare but serious possibility. Seek emergency medical attention immediately if you experience signs of a severe allergic reaction. This list does not include all possible side effects; consult your healthcare provider or pharmacist about potential reactions before starting this medication.